Stimcell Energetics Inc's Comment on Sales, Marketing and Customers
The Company operates in the medical device sector, specializing in microcurrent therapeutic devices for wellness and pain relief utilizing eBalance® Technology. Its primary markets include the United States, Canada, and Europe, with intentions to expand into other countries with comparable regulatory frameworks. The Company previously held Class II Medical Device Licenses from Health Canada for the eBalance® Home System and the eBalance® Pro System; however, these licenses were lost following the cancellation of required audits. Consequently, sales of these systems and associated online treatment packages have been suspended. In the United States, the Company must obtain FDA approval through a 510(k) submission to market its products, but this submission was withdrawn due to financial constraints. The Company also engages with third-party payers and private insurers, although reimbursement is not assured. Regulatory bodies referenced include BSI Group Canada Inc., Health Canada, and the U.S. Food and Drug Administration.
Stimcell Energetics Inc’s Comment on Sales, Marketing and Customers
The Company operates in the medical device sector, specializing in microcurrent therapeutic devices for wellness and pain relief utilizing eBalance® Technology. Its primary markets include the United States, Canada, and Europe, with intentions to expand into other countries with comparable regulatory frameworks. The Company previously held Class II Medical Device Licenses from Health Canada for the eBalance® Home System and the eBalance® Pro System; however, these licenses were lost following the cancellation of required audits. Consequently, sales of these systems and associated online treatment packages have been suspended. In the United States, the Company must obtain FDA approval through a 510(k) submission to market its products, but this submission was withdrawn due to financial constraints. The Company also engages with third-party payers and private insurers, although reimbursement is not assured. Regulatory bodies referenced include BSI Group Canada Inc., Health Canada, and the U.S. Food and Drug Administration.
Sources:
Stimcell Energetics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Stimcell Energetics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Stimcell Energetics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
